Showing results (551-560 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|May 23, 2015
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspectiveStephane A Régnier, William Malcolm, Jennifer Haig, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 21, 2020
Cost of Hypertension Illness and Associated Factors Among Patients Attending Hospitals in Southwest Shewa Zone, Oromia Regional State, EthiopiaAddisu Bogale Zawudie, Teferi Daba Lemma, Dawit Wolde Daka
Clinicoeconomics and Outcomes Research : CEOR|April 30, 2020
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid ArthritisCeline J Van De Laar, Martijn A H Oude Voshaar, Walid K H Fakhouri, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 17, 2021
Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United StatesAnshul Shah, Jonathan C Tosh, Apoorva Ambavane, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 17, 2021
Payer Perspectives on Intravenous versus Subcutaneous Administration of DrugsRobert S Epstein
Clinicoeconomics and Outcomes Research : CEOR|September 5, 2025
Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in ThailandJongkonnee Chongpornchai, Tuangrat Phodha, Thanawat Wongphan, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2016
Erratum: Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]
Clinicoeconomics and Outcomes Research : CEOR|May 19, 2021
Barriers and Facilitators of Community-Based Health Insurance Policy Renewal in Low- and Middle-Income Countries: A Systematic ReviewMohammed Hussien, Muluken Azage
Pageof 102